MCK · XBRL financial data

McKESSON financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (MCK's year ends in late March)

In millions of dollars	FY 2021Mar 31, 2021	FY 2022Mar 31, 2022	FY 2023Mar 31, 2023	FY 2024Mar 31, 2024	FY 2025Mar 31, 2025	FY 2026Mar 31, 2026
Revenue from contracts with customers	238,228	263,966	276,711	308,951	359,051	403,430
Cost of goods and services sold	226,080	250,836	264,353	296,123	345,728	388,880
Gross profit	12,148	13,130	12,358	12,828	13,323	14,550
Selling, general and administrative	8,849	10,537	7,776	8,657	8,507	8,096
Total operating expenses	17,188	11,092	7,977	8,919	8,901	8,338
Operating income (loss)	(5,040)	2,038	4,381	3,909	4,422	6,212
Interest income	12	10	107	118	173	179
Interest expense	217	178	248	252	265	247
Other income (expense)	30	103	279	34	(38)	44
Income tax expense (benefit)	(695)	636	905	629	878	1,102
Net income (loss)	(4,539)	1,114	3,560	3,002	3,295	4,762
Earnings per share, basic USD per share	(28.26)	7.32	25.23	22.54	25.86	38.55
Earnings per share, diluted USD per share	(28.26)	7.23	25.03	22.39	25.72	38.38
Weighted average shares, basic millions of shares	161	152	141	133	127	124
Weighted average shares, diluted millions of shares	161	154	142	134	128	124

Fiscal years (MCK's year ends in late March)

In millions of dollars	FY 2021Mar 31, 2021	FY 2022Mar 31, 2022	FY 2023Mar 31, 2023	FY 2024Mar 31, 2024	FY 2025Mar 31, 2025	FY 2026Mar 31, 2026
Cash and cash equivalents	6,278	3,532	4,678	4,583	5,691	3,975
Inventory	19,246	18,702	19,691	21,139	23,001	24,207
Prepaid and other current assets	665	898	496	626	1,063	1,043
Total current assets	45,382	46,231	44,292	47,970	55,398	57,210
Property and equipment, net	2,581	2,092	2,177	2,316	2,502	2,668
Right-of-use asset	2,100	1,548	1,635	1,729	1,782	2,058
Goodwill	9,493	9,451	9,947	10,132	10,022	11,316
Total assets	65,015	63,298	62,320	67,443	75,140	82,323
Accounts payable	38,975	38,086	42,490	47,097	55,330	59,973
Accrued liabilities	3,987	4,543	4,195	4,915	4,825	5,490
Total current liabilities	44,103	48,466	47,957	52,357	61,604	67,017
Long-term debt	6,406	—	—	—	—	—
Lease liability, non-current	1,867	1,366	1,402	1,466	1,478	1,801
Retained earnings	8,202	9,030	12,295	14,978	17,921	22,291
Total stockholders' equity	(21)	(2,272)	(1,857)	(1,971)	(2,074)	(2,172)
Total liabilities and equity	65,015	63,298	62,320	67,443	75,140	82,323
Common shares outstanding (cover page) millions of shares	158	145	136	130	125	120

Fiscal years (MCK's year ends in late March)

In millions of dollars	FY 2021Mar 31, 2021	FY 2022Mar 31, 2022	FY 2023Mar 31, 2023	FY 2024Mar 31, 2024	FY 2025Mar 31, 2025	FY 2026Mar 31, 2026
Net income (loss)	(4,539)	1,114	3,560	3,002	3,295	4,762
Depreciation and amortization	344	312	272	279	272	287
Net cash from operating activities	4,542	4,434	5,159	4,314	6,085	6,155
Purchases of property and equipment	451	388	390	431	537	436
Net cash from investing activities	(415)	(89)	(542)	(1,072)	(733)	(3,432)
Share repurchases	770	3,516	3,638	3,025	3,146	4,750
Dividends paid	276	277	292	314	345	381
Proceeds from long-term debt	500	498	997	991	498	1,990
Repayments of long-term debt	1,040	1,648	1,274	288	519	1,207
Net cash from financing activities	(1,693)	(6,321)	(4,368)	(3,342)	(3,965)	(4,631)
Net change in cash	2,373	(2,461)	744	(94)	1,371	(1,888)

SIC 5122 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen

SIC 5122 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Fewer than three companies fall in that range, so the list adds same-SIC (5122) companies nearest in public float, each marked “added: same SIC”.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
McKesson	6,528	110,957	3,070*	115.5M	—	Q2 FY27 10-QSep 30, 2026
Cardinal Health	4,856	year only	year only	232.6M	—	Q4 FY26 10-KJun 30, 2026
Cencora	2,815	84,755	2,654*	190.8M	—	Q3 FY26 10-QJun 30, 2026
Herbalifeadded: same SIC	409	1,350	151*	104.9M	—	Q3 FY26 10-QSep 30, 2026
Nu Skin Enterprisesadded: same SIC	190	320	11*	48.7M	—	Q2 FY26 10-QJun 30, 2026
DataMeds AIadded: same SIC	2.5	1.8	(2.9)*	3.1M	0.8 quarters	Q2 FY26 10-QJun 30, 2026
Cosmos Healthadded: same SIC	1.8	19	(1.7)*	100.6M	1.1 quarters	Q2 FY26 10-QJun 30, 2026
Stemtechadded: same SIC	0.2	0.6	(0.1)*	3.0B	4.5 quarters	Q2 FY26 10-QJun 30, 2026
Sharing Services Globaladded: same SIC	0.7	2.1	(0.4)*	309,652	1.7 quarters	Q2 FY25 10-QSep 30, 2024

Not investment advice. Not affiliated with the U.S. SEC.